Interoceptive awareness mediates the relationship between hypoglycemia exposure and the glycemic threshold for symptom recognition in T1D.
Tirzepatide use is associated with a lower risk for CPAP use, hospitalization, and mortality in adults with obesity, T2D, and OSA.